These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1465079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease.
    Morita S, Fukuhara S, Akizawa T, Asano Y, Koshikawa S, Koide K, Kurokawa K.
    Ther Apher Dial; 2006 Feb; 10(1):72-7. PubMed ID: 16556140
    [Abstract] [Full Text] [Related]

  • 6. Stockholm clinical study on progression of chronic renal failure--an interim report.
    Bergström J, Alvestrand A, Bucht H, Gutierrez A.
    Kidney Int Suppl; 1989 Nov; 27():S110-4. PubMed ID: 2636644
    [Abstract] [Full Text] [Related]

  • 7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 8. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications.
    Rosman JB, Langer K, Brandl M, Piers-Becht TP, van der Hem GK, ter Wee PM, Donker AJ.
    Kidney Int Suppl; 1989 Nov; 27():S96-102. PubMed ID: 2636680
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Nov; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 13. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 14. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in renal function in renal transplantation. Predictive factors for functional deterioration].
    Jiménez del Cerro LA, Franco A, Rivera F, Olivares J.
    Nefrologia; 2001 Jan; 21(3):295-304. PubMed ID: 11471310
    [Abstract] [Full Text] [Related]

  • 17. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jan; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 18. [The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
    Zoghi M, Duygu H, Güngör H, Nalbantgil S, Yilmaz GM, Tülüce K, Ozerkan F, Akilli A, Akin M.
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):255-9. PubMed ID: 18676300
    [Abstract] [Full Text] [Related]

  • 19. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database.
    Ardissino G, Viganò S, Testa S, Daccò V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, La Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch IM, ItalKid Project.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2525-30. PubMed ID: 17526542
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting progression of renal insufficiency.
    Locatelli F, Manzoni C, Marcelli D.
    Miner Electrolyte Metab; 1997 Sep; 23(3-6):301-5. PubMed ID: 9387138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.